↓ Skip to main content

Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses

Overview of attention for article published in Health Economics Review, April 2012
Altmetric Badge

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
91 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Published in
Health Economics Review, April 2012
DOI 10.1186/2191-1991-2-8
Pubmed ID
Authors

Antonio J García-Ruiz, Lucía Pérez-Costillas, Ana C Montesinos, Javier Alcalde, Itziar Oyagüez, Miguel A Casado

Abstract

Schizophrenia is a severe form of mental illness which is associated with significant and long-lasting health, social and financial burdens.The aim of this project is to assess the efficiency of the antipsychotics used in Spain in reducing schizophrenia relapses under the Spanish Health System perspective.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
United States 1 1%
Unknown 89 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 19%
Researcher 15 16%
Student > Ph. D. Student 7 8%
Student > Doctoral Student 7 8%
Student > Bachelor 7 8%
Other 24 26%
Unknown 14 15%
Readers by discipline Count As %
Medicine and Dentistry 24 26%
Economics, Econometrics and Finance 12 13%
Pharmacology, Toxicology and Pharmaceutical Science 8 9%
Psychology 5 5%
Nursing and Health Professions 4 4%
Other 15 16%
Unknown 23 25%